Single cell DNA and RNA sequencing of MPN patients has highlighted that acquiring additional mutations, such as those in TET2 and EZH2, in a particular order play a role in the development of specific subsets of MPN [31]. This evidence concerns the gene EZH2 and myeloproliferative disorder.